DOCSLIB.ORG

Messages 4144-4221

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Messages 4144-4221 Digest Pagina 1 di 65 Messages in vasculab group. Page 1 of 1. Group: vasculab Message: 4144 From: Waldemar L. Olszewski Date: 06/02/2011 Subject: Re: MEVc Course Group: vasculab Message: 4145 From: MUDr. Andrej Džupina Date: 06/02/2011 Subject: Re: MEVc Course Group: vasculab Message: 4147 From: Dr.D.Eckert Date: 07/02/2011 Subject: Re: MEVc Course Group: vasculab Message: 4150 From: Giancarlo Bracale Date: 09/02/2011 Subject: Re: MEVc Course Group: vasculab Message: 4153 From: bblee Date: 10/02/2011 Subject: Re: MEVc Course Group: vasculab Message: 4157 From: Nada Theivacumar Date: 10/02/2011 Subject: Re: MEVc Course Group: vasculab Message: 4158 From: Dr.D.Eckert Date: 10/02/2011 Subject: Re: MEVc Course Group: vasculab Message: 4159 From: Nick Morrison Date: 10/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4160 From: bblee Date: 10/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4161 From: [email protected] Date: 11/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4162 From: Albert Adrien RAMELET Date: 11/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4163 From: Pier Luigi Antignani Date: 11/02/2011 Subject: R: [vasculab] Lymphatic Group: vasculab Message: 4164 From: Dr.D.Eckert Date: 11/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4165 From: bblee Date: 11/02/2011 file:///H:/xsl -fo/fop -2.0/jtavr/jtavr01/jtavr012/JTAVR000017 -PassarielloF/Phlebolymphedema%20Feb%206 -20,%202011%20 -%20 ©%2 ... 30/ 04/ 2017 Digest Pagina 2 di 65 Subject: Re: Lymphatic Group: vasculab Message: 4166 From: bblee Date: 11/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4167 From: [email protected] Date: 12/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4168 From: Hirai Date: 12/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4170 From: [email protected] Date: 12/02/2011 Subject: R: [vasculab] Lymphatic Group: vasculab Message: 4172 From: mauroand Date: 12/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4173 From: Dr.D.Eckert Date: 13/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4175 From: Julio Ferreira Date: 13/02/2011 Subject: Re: R: [vasculab] Lymphatic Group: vasculab Message: 4176 From: bblee Date: 13/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4177 From: bblee Date: 13/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4178 From: jane wigg Date: 13/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4179 From: Horst Rieger Date: 13/02/2011 Subject: Re: R: [vasculab] Lymphatic Group: vasculab Message: 4180 From: Armer, Jane Date: 13/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4181 From: [email protected] Date: 13/02/2011 Subject: Rif: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4182 From: [email protected] Date: 14/02/2011 Subject: R: Rif: RE: RE: [vasculab] Lymphatic file:///H:/xsl -fo/fop -2.0/jtavr/jtavr01/jtavr012/JTAVR000017 -PassarielloF/Phlebolymphedema%20Feb%206 -20,%202011%20 -%20 ©%2... 30/ 04/ 2017 Digest Pagina 3 di 65 Group: vasculab Message: 4183 From: Alessandro Pieri Date: 14/02/2011 Subject: Re: Rif: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4184 From: bblee Date: 14/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4185 From: bblee Date: 14/02/2011 Subject: Re: Rif: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4186 From: bblee Date: 14/02/2011 Subject: Re: Rif: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4187 From: Leonardo Corcos Date: 14/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4188 From: [email protected] Date: 14/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4189 From: Alberto Caggiati Date: 14/02/2011 Subject: Re: Rif: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4190 From: Hugo Partsch Date: 14/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4191 From: bblee Date: 14/02/2011 Subject: Re: Rif: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4192 From: bblee Date: 14/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4193 From: [email protected] Date: 15/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4194 From: claude franceschi Date: 15/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4195 From: [email protected] Date: 15/02/2011 Subject: Rif: Re: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4196 From: Alberto Caggiati Date: 15/02/2011 Subject: Lymphatic failure and CEAP Group: vasculab Message: 4197 From: Ermes Pasqual Date: 15/02/2011 file:///H:/xsl -fo/fop -2.0/jtavr/jtavr01/jtavr012/JTAVR000017 -PassarielloF/Phlebolymphedema%20Feb%206 -20,%202011%20 -%20 ©%2... 30/ 04/ 2017 Digest Pagina 4 di 65 Subject: Ogg:Phlebolyphedema term Group: vasculab Message: 4198 From: Hugo Partsch Date: 15/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4199 From: Waldemar L. Olszewski Date: 15/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4200 From: bblee Date: 15/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4201 From: [email protected] Date: 15/02/2011 Subject: R: Re: [vasculab] Lymphatic failure and CEAP Group: vasculab Message: 4202 From: Alessandro Pieri Date: 16/02/2011 Subject: Re: Rif: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4203 From: claude franceschi Date: 16/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4204 From: Robert A Weiss Date: 16/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4205 From: bblee Date: 16/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4206 From: bblee Date: 16/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4207 From: bblee Date: 16/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4208 From: bblee Date: 16/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4209 From: bblee Date: 16/02/2011 Subject: Re: Rif: RE: RE: [vasculab] Lymphatic Group: vasculab Message: 4210 From: sur2 Date: 16/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4211 From: [email protected] Date: 16/02/2011 Subject: R: [vasculab] Lymphatic failure and CEAP file:///H:/xsl -fo/fop -2.0/jtavr/jtavr01/jtavr012/JTAVR000017 -PassarielloF/Phlebolymphedema%20Feb%206 -20,%202011%20 -%20 ©%2... 30/ 04/ 2017 Digest Pagina 5 di 65 Group: vasculab Message: 4212 From: Alfred Bollinger Date: 16/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4213 From: Foeldiklinik Hinterzarten Date: 16/02/2011 Subject: Lymphatic Group: vasculab Message: 4214 From: bblee Date: 17/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4215 From: bblee Date: 17/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4216 From: Alfred Bollinger Date: 17/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4217 From: bblee Date: 17/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4218 From: Prof. Corradino Campisi Date: 17/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4219 From: Waldemar L. Olszewski Date: 19/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4220 From: [email protected] Date: 19/02/2011 Subject: Re: Lymphatic failure and CEAP Group: vasculab Message: 4221 From: bblee Date: 20/02/2011 Subject: Re: Lymphatic Group: vasculab Message: 4144 From: Waldemar L. Olszewski Date: 06/02/2011 Subject: Re: MEVc Course Waldemar L Olszewski MD, Warsaw  Dear Colleagues,  file:///H:/xsl -fo/fop -2.0/jtavr/jtavr01/jtavr012/JTAVR000017 -PassarielloF/Phlebolymphedema%20Feb%206 -20,%202011%20 -%20 ©%2... 30/ 04/ 2017 Digest Pagina 6 di 65 The VASCULAB is most active in the field of phlebology. Fantastic accomplishments. However, there is something lacking. This is information and discussion on the lymphatic system. Both the venous and lymphatic circulation in parallel return fluid to the blood circulation, one would not exist without the other. Lymphology is developing fast and can not exists without phlebology. I propose to create a subchapter of VASCULAB devoted to pathophysiology, diagnosis and therapy of diseases of the lymphatic system. More than 300 million people around the world affected (WHO data). I organize a congress of the European Society for Lymphology, June 3-4,2011, Warsaw, Poland www.ESL2011.info It could be a good start for creating the phlebolymphological family.   Waldemar L Olszewski MD Professor of Surgery frm President of the International Society for Lymphology 2011/2/6 [email protected] <[email protected] Group: vasculab Message: 4145 From: MUDr. Andrej Džupina Date: 06/02/2011 Subject: Re: MEVc Course Dear Profesor Olszewski, I am so happy and aggre with you. Lymphology is most important parf of flebology, or this two systems must bez workink in cooperation . You propose is wery good. Best regards a.džupina Bardejov Slovakia Group: vasculab Message: 4147 From: Dr.D.Eckert Date: 07/02/2011 Subject: Re: MEVc Course I finde, it´s a very good idear! Thank You for it! Dr. Daniela Eckert/Hagenow-Germany Group: vasculab Message: 4150 From: Giancarlo Bracale Date: 09/02/2011 file:///H:/xsl -fo/fop -2.0/jtavr/jtavr01/jtavr012/JTAVR000017 -PassarielloF/Phlebolymphedema%20Feb%206 -20,%202011%20 -%20 ©%2... 30/ 04/ 2017 Digest Pagina 7 di 65 Subject: Re: MEVc Course I too agree with you sincerely yours Giancarlo Bracale, MD Professor of Vascula Surgery Chief Dept. Vascular and Endovascular Surgery Director of Post-Graduated School of Vascular Surgery University Federico II of Naples Group: vasculab Message: 4153 From: bblee Date: 10/02/2011 Subject: Re: MEVc Course Couldn't agree more with Professor Olszewski. Such feeling is now shared from the both sides of the Atlantic. Indeed, American Venous Forum at the helm leading the venous field decided to dedicate one separate/independent symposium only for the lymphedema for the first time through upcoming annual meeting in San Diego in late February- I invited Drs.
Load more

Recommended publications
  • Surgical Treatment of Varicose Veins with the CHIVA Method
    Review Operative Behandlung der Varikose nach der CHIVA-Methode Surgical treatment of varicose veins with the CHIVA method Autoren Erika Mendoza Institut und Spanien durchgesetzt, im Moment hält es seinen Einzug in Venenpraxis, Wunstorf China und in den osteuropäischen Ländern, primär dort, wo der Duplex als Grundlage für die phlebologische Diagnostik zählt Schlüsselwörter und eine kostengünstige Herangehensweise vom Gesundheits- Chronische venöse Insuffizienz, Saphenareflux, Venenerhalt, wesen gefordert wird. CHIVA Das Verfahren kann bei jeder Ausprägung der Varikose und jedem Stadium der chronischen venösen Insuffizienz ange- Key words wendet werden, wobei der Erhalt einer postthrombotisch ver- chronic venous insufficiency, reflux in saphenous vein, änderten Stammvene nicht anstrebenswert erscheint. Eine vein preservation, CHIVA Metaanalyse (Cochrane-Review) bescheinigt CHIVA weniger Rezidive bei gleichwertigem Erstergebnis und weniger Neben- eingereicht 09.11.2018 wirkungen im Vergleich zum Stripping, wobei weitere Studien akzeptiert ohne Revision 14.03.2019 mit höheren Patientenzahlen gefordert werden. Die neuen Techniken, wie endoluminale (Hitze-) Verfahren Bibliografie und schallgesteuerte Schaumverödung haben das Verfahren DOI https://doi.org/10.1055/a-0877-8781 noch minimal-invasiver gemacht, sodass die ohnehin geringe Online Publikation: 02.05.2019 Komplikationsrate und die kurze Arbeitsunfähigkeitszeit noch Phlebologie 2019; 48: 153–160 verkürzt werden kann. © Georg Thieme Verlag KG Stuttgart · New York ISSN 0939-978X ABSTRACT Korrespondenzadresse In 1988, just after the upcoming of duplex ultrasound, the Dr. Erika Mendoza French vascular surgeon and angiologist Claude Franceschi de- Venenpraxis veloped a hemodynamic strategy to treat venous insufficiency Speckenstr. 10 on ambulatory patients. He gave the treatment the name of 31515 Wunstorf the French acronym. CHIVA. E-Mail: [email protected] The strategy is based on the preservation of draining path- ways, specially the saphenous veins.
    [Show full text]
  • CX Venous Programme 25–28 APRIL 2017, OLYMPIA GRAND, LONDON, UK ORGANISING BOARD: Ian Franklin, Stephen Black, Alun Davies and Andrew Bradbury
    Vascular & Endovascular Consensus Update Pathways of Care CONTROVERSIES CHALLENGES CONSENSUS CX Venous Programme 25–28 APRIL 2017, OLYMPIA GRAND, LONDON, UK ORGANISING BOARD: Ian Franklin, Stephen Black, Alun Davies and Andrew Bradbury Peripheral Acute Aortic Venous Arterial Stroke Consensus Consensus Consensus Consensus 25 APRIL 26–27 APRIL 28 APRIL CX Venous Consensus CX Venous Workshop Update – NEW CX Venous Edited CX Venous Abstracts Plenary Programme Cases Register at WWW.CXSYMPOSIUM.COM Early bird registration ends: 26 February 2017 EDUCATION INNOVATION EVIDENCE [email protected] CX Symposium @cxsymposium CX Venous Consensus Update – Plenary Programme 25 April 2017, Lower Main Auditorium Investigations of superficial and deep venous Pelvic vein congestion and reflux anatomy Prevalence of pelvic vein venous reflux and criteria for treatment Kathleen Gibson, Bellevue, United States WHETHER to intervene Prevalence of pelvic vein incompetence in women with chronic pelvic pain The best imaging modality – the implication of cost and influence on quality of life – scoring systems Alun Davies, London, United Kingdom Charles McCollum, Manchester, United Kingdom Computed tomography (CT) venography and magnetic resonance (MR) venography are performed in the horizontal position – suitability for assessing venous function Andrew Wigham, Oxford, United Kingdom Varicose vein management Value of fusion imaging to treat deep venous thrombosis INTERVENTION METHOD and outcomes Adrien Hertault, Lille, France Endovenous adhesive vs. radiofrequency
    [Show full text]
  • Download Download
    Veins and Lymphatics 2014; volume 3:1919 Multiple ligation of the Introduction Correspondence: Roberto Delfrate, Figlie di San proximal greater saphenous Camillo Hospital, via Fabio Filzi 56, 26100 vein in the CHIVA treatment The sapheno-femoral junction (SFJ) is a key Cremona, Italy. point for the venous drainage of the lower limb Tel.: +39.0372.421111 – Mobile: +39.334.9089110. of primary varicose veins E-mail: [email protected] from the foot up to the hip and gluteus, the Roberto Delfrate,1 Massimo Bricchi,1 lower abdominal wall and lower genital tract. Key words: saphenous-femoral disconnection, Claude Franceschi,2 Matteo Goldoni3 Moreover, the disconnection of the incompe- saphenous-femoral junction, neovascularization tent SFJ is a fundamental procedure to most recurrences, primary varicose vein surgery. 1 Surgery Unit, Figlie di San Camillo open superficial venous surgery.1-5 2 Hospital, Cremona, Italy; Angiology Unfortunately, most varicose recurrences are Received for publication: 11 September 2013. Consultant, Saint Joseph Hospital, Paris, due to SFJ neovascularization (recurrences) Revision received: 11 February 2014. France; 3Department of Consulting of observed in 25% to 94% of recurrent varicose Accepted for publication: 6 March 2014. Clinical Medicine, Nephrology and Health 6 veins. Conservative saphenous-femoral dis- This work is licensed under a Creative Commons Sciences, University of Parma, Italy connection is a very common surgical practice Attribution 3.0 License (by-nc 3.0). according to the conservative hemodynamic correction of venous insufficiency (CHIVA) ©Copyright R. Delfrate et al., 2014 method.7-12 For more than a decade we have Licensee PAGEPress, Italy Abstract tested a technique that requires a division of Veins and Lymphatics 2014; 3:1919 the SFJ and others that require only peculiar doi:10.4081/vl.2014.1919 Saphenous femoral disconnection is the key ligatures without division of the incompetent point of most surgical techniques in the treat- saphenous femoral tract.
    [Show full text]
  • Corso Di Formazione
    lli Clinic 015 2 , 16 1st International Haemodynamic Aula Magna of the Mangiaga Symposium on Venous Disorders - Haemodynamic aspects of physiopathology, diagnosis and therapy of the venous disease October 15 and , e Policlinico Hospital of Milan M i l a n Maggior Introduction In recent decades we have Scientific Board witnessed a great revolution in the approach to venous diseases thanks to the increasing understanding of the physiopathologicical mechanisms that cause the typical pathological signs of venous insufficiencies. The introduction of no n-in vasive Prof. Livio Gabrielli diagnostics with the continuous wave Doppler and subsequently with the Echo Color Doppler enabled us to acquire detailed information on the physiological mechanisms of venous circulation and consequently on the physiopathological m echanism s . This allowed for a new close examination of the events and Prof. Claude Franceschi hemodynamic changes that trigger the onset of the clinical abnormalities characteristic of venous insufficiencies. This development has greatly benefitted diagnosis and therapy not only of the superficial venous insufficiencies but also of the deep venous Dott. Roberto Delfrate insufficiencies, which are common in post-thrombosis syndrome. In the last twenty-five years, non -in vas ive hemodynamic ultrasound diagnostics together with technological developments have broade ned therapeutic options. These include conservative hemodynamic therapy and also the progressive development of different forms of m inim ally- invasive therapies which intend to offer alternatives to stripping that are easier to implement. The hemodynamic CH IVA strategy (Conservatrice et Hemodynamique de l'Insuffisance Veineuse en Ambulatoire) codified by Claude Franceschi, a pioneer who played a major role in the development and spreading of the Doppler ultrasound vascular investigation both in the arterial a nd venous districts, appeared in 1988 as an alternative to demolition therapies.
    [Show full text]
  • 1 the Ultrasound Scanner 1 2 Anatomy of the Superficial Veins 19
    1 The Ultrasound Scanner 1 Hans-Peter Weskott, Erika Mendoza, and Christopher R. Lattimer 2 Anatomy of the Superficial Veins 19 Alberto Caggiati, Erika Mendoza, Renate Murena-Schmidt, and Christopher R. Lattimer 3 Pathophysiology of the Superficial Venous System 49 Erika Mendoza, Claude Franceschi, Birgit Kahle, and Christopher R. Lattimer 4 Ultrasound-Based Classifications of Varicose Veins 67 Erika Mendoza and Christopher R. Lattimer 5 Duplex Ultrasound Examination of Superficial Leg Veins.... 93 Erika Mendoza, Nick Morrison, and Christopher R. Lattimer 6 Flow Provocation Manoeuvres for the Diagnosis of Venous Disease Using Duplex Ultrasound 105 Erika Mendoza and Christopher R. Lattimer 7 Examination of the Great Saphenous Vein 119 Erika Mendoza, Nick Morrison, and Christopher R. Lattimer 8 Examination of the Small Saphenous Vein 171 Erika Mendoza and Christopher R. Lattimer 9 Perforating Veins 187 Erika Mendoza and Christopher R. Lattimer 10 Tributaries 201 Erika Mendoza and Christopher R. Lattimer 11 Superficial Vein Thrombosis 217 Erika Mendoza and Christopher R. Lattimer 12 Ultrasound in Varicose Vein Treatment 227 Erika Mendoza, Thomas M. Proebstle, Achim Mumme, Franz Xaver Breu, Nick Morrison, and Christopher R. Lattimer http://d-nb.info/1038119928 xii 13 Ultrasound After Venous Intervention 247 Erika Mendoza,-Achim Mumme, Andreas Hildebrandt, Nick Morrison, and Christopher R. Lattimer 14 Deep Leg Veins 267 Hans-Joachim Kruse, Erika Mendoza, Nick Morrison, and Christopher R. Lattimer 15 Examination of Superficial Veins in the Presence of Deep Venous Disease 279 Erika Mendoza and Christopher R. Lattimer 16 Differential Diagnosis of Leg Oedemas of Venous and Lymphatic Origin 285 Erika Mendoza and Christopher R.
    [Show full text]
  • Non-Invasive Diagnosis of Chronic Venous Disorders
    162 NEWS IN ANGIOLOGY • ChrONIC vENOuS dISEASES nTheon-invasive mem-neT programdiagnosis 12 for chronicof cerebro-spinalchronic venous venous disorders insufficiency 43 color flow dopplerP.l. antignani imaging assessmenT s . Mandolesi, a. d’alessandro Chronic venous insufficiency (CVI) is the con- of investigation is the color Doppler ultrasound dition in which one or more veins become unable imaging (CDUI)). For more proximal vessels such to fulfill their three specific functions:1 as those of the pelvis magnetic resonance imaging – drainage from the tissues of toxic substances; (MRI) is very reliable for the detection of throm- – filling of the heart cavities; bosis. – thermoregulation of tissues; In 1988 with the birth of the conservative he- in any physical activity or position of the subject. modynamic ambulatory treatment of varicose What is the event that causes the CVI? veins, Claude Franceschi has realized the first Any condition that poses an obstacle to the cartographic maps of venous hemodynamics of drainage of one or more veins it is the cause that the lower limbs.1 In 1992, the authors showed for in time will determine the appearance of clinical the first time the venous compression syndrome disorders manifested as CVI. (VCS) of the lower limbs 2 and in 2011 that of the The CVI has been studied mainly for its effects veins draining cerebral spinal flow.3 The VCS has on the circulation of the lower limbs. Specifically, widened the field of interest of the phlebologists lower limb varicose veins are characterized first by and lead to static and dynamic biomechanic stud- the dilation of the veins and gradually, over the ies.
    [Show full text]
  • Development of a Deep Vein Valve Replacement
    Development of a Deep Vein Valve Replacement Thesis submitted to Imperial College London for the degree of Doctor of Philosophy Miss Hayley Moore MA (Cantab), MBBS (AICSM), MRCS (Eng) Registration 1st October 2010 Supervisors Professor Alun H Davies (Vascular Surgery) Professor Molly Stevens (Biomedical Materials) Professor Yun Xu (Biofluid Mechanics) Mr Manj Gohel (Vascular Surgery) 1 CONTENTS Contents ........................................................................................................................................................................ 2 Abstract ......................................................................................................................................................................... 8 Acknowledgements .................................................................................................................................................... 10 Statement of Originality ............................................................................................................................................ 11 List of Tables .............................................................................................................................................................. 12 List of Figures ............................................................................................................................................................. 14 Abbreviations.............................................................................................................................................................
    [Show full text]
  • Non-Commercial Use Only
    Veins and Lymphatics 2018; volume 7:7199 Who knows the rationale of the According to Cestmir Recek’s the strain refilling time measured by gauge measurements improved the plethys- Correspondence: Claude Franceschi, Centre mographic parameters as follows: de soins Marie Thérèse, Paris, France. plethysmography? After great saphenous vein (GSV) E-mail: [email protected] crossectomy, the mean of 30 measurements Key words: Plethysmography; venous patho- Claude Franceschi was: refill time t-90 by 24.5 s; t-50 by 10.6 physiology; chronic venous insufficiency; Centre de soins Marie Thérèse, Paris, s; refill volume by 0.94 mL/100 mL (a mean CHIVA; saphenous ablation; lower limb of 30 measurements).1 France drainage. After crossectomy and stripping, the mean of 18 measurements was: refill time t- This work is licensed under a Creative 90 by 26.2 s; t-50 by 10.8 s; refill volume by Commons Attribution 4.0 License (by-nc 4.0). Abstract 1.1 mL/100 mL.² The Recek’s conclusion was: the differ- ©Copyright C. Franceschi, 2018 This mini-review analyzes the patho- Licensee PAGEPress, Italy ences were minimal and the postoperative Veins and Lymphatics 2018; 7:7199 physiology significance of the refilling time results both after high ligation and after doi:10.4081/vl.2018.7199 (RT) assessed in limbs after exercise by the high ligation plus stripping were well in the means of plethysmographic techniques. range of normal values. Based on such a rationale the Author offers The hemodynamic analysis of these an interpretation of RT following suppres- results shows limitations and sometimes gery does not take into account all the sion of reflux points respectively achieved misinterpretations of the data.
    [Show full text]
  • CHIVA to Treat Saphenous Vein Insufficiency in Chronic
    REVIEW ARTICLE ISSN 1677-7301 (Online) CHIVA to treat saphenous vein insufficiency in chronic venous disease: characteristics and results CHIVA para tratar insuficiência de veia safena em doença venosa crônica: características e resultados Felipe Puricelli Faccini1,2 , Stefano Ermini3 , Claude Franceschi4,5 Abstract There is considerable debate in the literature with relation to the best method to treat patients with chronic venous disease (CVD). CHIVA is an office-based treatment for varicose veins performed under local anesthesia. The aim of the technique is to lower transmural pressure in the superficial venous system and avoid destruction of veins. Recurrence of varicosities, nerve damage, bruising and suboptimal aesthetic results are common to all treatments for the disease. This paper evaluates and discusses the characteristics and results of the CHIVA technique. We conclude that CHIVA is a viable alternative to common procedures that is associated with less bruising, nerve damage, and recurrence than stripping saphenectomy. The main advantages are preservation of the saphenous vein, local anesthesia, low recurrence rates, low cost, low pain, and no nerve damage. The major disadvantages are the learning curve and the need to train the team in venous hemodynamics. Keywords: CHIVA; saphenous sparing; local anesthesia; varicose vein; chronic venous disease. Resumo Existe uma grande discussão na literatura sobre o tratamento da doença venosa crônica (DVC). A cura conservadora e hemodinâmica da insuficiência venosa em ambulatório (CHIVA) consiste no tratamento ambulatorial de varizes sob anestesia local. O objetivo da técnica é diminuir a pressão transmural no sistema venoso superficial para evitar a destruição das veias, incluindo as veias safenas.
    [Show full text]
  • LATEST FRONTIERS of Hemodynamics, Imaging and Treatment of OBSTRUCTIVE VENOUS DISEASE
    Alessia Giaquinta • Byung-Boong Lee • Carlo Setacci Pierfrancesco Veroux • Paolo Zamboni LATEST FRONTIERS of Hemodynamics, Imaging and Treatment of OBSTRUCTIVE VENOUS DISEASE With the collaboration of Massimiliano Veroux • Sonia Ronchey EDIZIONI MINERVA MEDICA 00_Romane.indd III 03/01/18 10:24 This book has been supported by an unrestricted educationl grant from ISBN: 978-88-7711-929-2 Th e publisher declares himself fully available to resolve any eventuality related to the reproduction of the cover image, for which the source was not found. © 2018 – EDIZIONI MINERVA MEDICA S.p.A. – Corso Bramante 83/85 – 10126 Torino www.minervamedica.it / e-mail: [email protected] All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means. 00_Romane.indd IV 03/01/18 10:24 Preface Th is new book, “Latest Frontiers of Hemo- high fi elds. Lastly, MRI can also be used to map dynamics, Imaging and Treatment of Obstruc- CSF fl ow and diff usion over time. All of these tive Venous Disease”, is a welcome addition to features help to promote a fundamental under- the literature espousing the importance of the standing of the role of the venous system. role of the venous system in human physiology Th is book is composed of two main parts. and the treatment of venous abnormalities. Th e Th e fi rst part contains the study and treatment many authors of this text are leaders in the fi eld of large veins. Vein anatomy and function are and provide a prescient outlook to both cur- presented as introductory concepts in Chapters rent and future technology.
    [Show full text]
  • Minerva Medica Copyright®
    Anno: 2016 Lavoro: 3580-ANGY Mese: February titolo breve: CHIVA: hemodynamic concept, strategy and results Volume: 35 primo autore: FRANCESCHI No: 1 pagine: 8-30 Rivista: INTERNATIONAL ANGIOLOGY Cod Rivista: International Angiology , Copyright © 2016 @EDIZIONI MINERVA MEDICA International Angiology 2016 February;35 (1):8-30 ORIGINAL ARTICLE CHIVA: hemodynamic concept, strategy and results Claude FRANCESCHI 1, Massimo CAPPELLI 2, Stefano ERMINI 3, Sergio GIANESINI 4* Erika MENDOZA 5, Fausto PASSARIELLO 6, Paolo ZAMBONI 4 1Centre Marie Therese Hopital Saint Joseph, Paris, France; 2Private Practitioner, Florence, Italy; 3Private Practitioner, Grassina, Flor- ence, Italy; 4Vascular Diseases Center, University of Ferrara, Italy; 5Venenpraxis, Wunstorf, Germany; 6Diagnostic Centre Aquarius, Napoli, Italy *Corresponding author: Sergio Gianesini, Vascular Disease Center, University of Ferrara Italy, Via Aldo Moro 8, 44124 Loc Cona, Ferrara, Italy. E-mail: [email protected] ABSTRACT The first part of this review article provides the physiologic background that sustained the CHIVA principles development. Then the venous networks anatomy and flow patterns are described with pertinent sonographic interpretations, leading to the shunt concept description and to the consequent CHIVA strategy application. An in depth explanation into the hemodynamic conservative cure approach follows, together with pertinent review of the relevant literature. (Cite this article as: Franceschi C, Cappelli M, Ermini S, Gianesini S, Mendoza E, Passariello F et al. CHIVA: hemodynamic concept, strategy and results. Int Angiol 2016;35:8-30) Key words: Venous insufficiency - Hemodynamics - Saphenous Vein - Ultrasonography, Doppler, Duplex. HIVA is a French acronym for “Cure conservatrice sequently suppressing the pressure overload by tar- Cet Hemodynamique de l’Insuffisance Veineuse en geted ligations that are customized on each specific Ambulatoire” (Conservative and Hemodynamic treat- reflux pattern.
    [Show full text]
  • Non-Commercial Use Only
    Veins and Lymphatics 2019; volume 8:8020 The overtreatment of illusory pletely mirrored by the modern IVUS, May Thurner syndrome which currently may nicely depict truncular Correspondence: Paolo Zamboni, Chair venous malformations (Figure 3). It is Center for Veins and Lymphatics Diseases mandatory to improve preoperative diag- Regione Emilia Romagna, University 1 2 Paolo Zamboni, Claude Franceschi, nostics to avoid useless and harmful Hospital of Ferrara, Via Aldo Moro 8, 44124 3 Roberto Del Frate overtreatment to arrive at correct surgical Cona (FE), Italy. E-mail: [email protected] 1Center for Veins and Lymphatics indications. It is clear that illusory MTS Diseases Regione Emilia Romagna, occurs whenever the compression is Key words: May Thurner syndrome; editorial. University Hospital of Ferrara, Cona reversible. The ultrasound manoeuver here- 2 in described could become an initial screen- (FE), Italy; Groupe Hospitalier Paris Received for publication: 2 January 2019. ing useful also to avoid more invasive or Revision received: 3 January 2019. Saint-Joseph, Paris, France; 3Casa di expensive diagnostic steps, demonstrating Accepted for publication: 4 January 2019. Cura Figlie di San Camillo, Cremona, rapidly the presence of illusory MTS. To the Italy contrary, the real MTS is related to not This work is licensed under a Creative reversible compression and/or to associated Commons Attribution 4.0 License (by-nc 4.0). intraluminal defects. ©Copyright P. Zamboni et al., 2019 Introduction Licensee PAGEPress, Italy Veins and Lymphatics 2019; 8:8020 Recently, an excellent article of van doi:10.4081/vl.2019.8020 Vuuren et al. described in healthy volun- teers an impressive prevalence of angio- graphic signs usually indicative of May Turner syndrome (MTS).1 In 80% of participants, at least two signs indicative of May-Thurner compres- sion were seen.
    [Show full text]